These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25897756)

  • 1. Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA.
    Chung BH; Joo YY; Lee J; Kim HD; Kim JI; Moon IS; Choi BS; Oh EJ; Park CW; Kim YS; Yang CW
    PLoS One; 2015; 10(4):e0123638. PubMed ID: 25897756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
    Ko EJ; Yu JH; Yang CW; Chung BH;
    Transpl Int; 2017 Dec; 30(12):1215-1225. PubMed ID: 28493630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.
    Dörje C; Mjøen G; Strøm EH; Holdaas H; Jenssen T; Øyen O; Akkök ÇA; Cvancarova M; Midtvedt K; Reisaeter AV
    Clin Transplant; 2015 Mar; 29(3):268-76. PubMed ID: 25644963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors.
    Toki D; Ishida H; Setoguchi K; Shimizu T; Omoto K; Shirakawa H; Iida S; Horita S; Furusawa M; Ishizuka T; Yamaguchi Y; Tanabe K
    Am J Transplant; 2009 Mar; 9(3):567-77. PubMed ID: 19260836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study.
    Kwon H; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Kim YH; Han DJ;
    Sci Rep; 2019 Dec; 9(1):18229. PubMed ID: 31796812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens.
    Subramanian V; Gunasekaran M; Gaut JP; Phelan D; Vachharajani N; Santos RD; Wellen J; Shenoy S; Mohanakumar T
    Hum Immunol; 2016 Jan; 77(1):76-83. PubMed ID: 26476207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
    PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage of CD19
    Hirose T; Iwami D; Hotta K; Sasaki H; Higuchi H; Shinohara N
    Transplant Proc; 2019 Jun; 51(5):1382-1386. PubMed ID: 31027828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.
    Couzi L; Manook M; Perera R; Shaw O; Ahmed Z; Kessaris N; Dorling A; Mamode N
    Transpl Int; 2015 Oct; 28(10):1205-15. PubMed ID: 26095452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort study.
    Deng Y; Frischnknecht L; Wehmeier C; de Rougemont O; Villard J; Ferrari-Lacraz S; Golshayan D; Gannagé M; Binet I; Wirthmueller U; Sidler D; Schachtner T; Schaub S; Nilsson J
    Front Immunol; 2024; 15():1355128. PubMed ID: 38361942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy.
    Chung BH; Choi BS; Oh EJ; Park CW; Kim JI; Moon IS; Kim YS; Yang CW
    Transpl Int; 2014 Jan; 27(1):49-59. PubMed ID: 24118413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.